Pharma channel feed

Ky­owa Kirin brings rare dis­ease drug's mar­ket­ing back in house, plots fu­ture US growth

3 years ago
Marketing

Vivek Ra­maswamy is run­ning an an­ti-“woke,” an­ti-Chi­na pres­i­den­tial cam­paign. It's a con­trast to his time as CEO

3 years ago
People

FDA ap­proves Avadel's nar­colep­sy drug af­ter courts forced Jazz patent delist­ing

3 years ago
FDA+

PhRMA re­news phar­ma­cy ben­e­fits man­ag­er cam­paign as Con­gres­sion­al scruti­ny heats up

3 years ago
Marketing

US gov­ern­men­t's court bat­tle be­gins over Gilead HIV drug patents

3 years ago
Law

Boehringer and Lon­za ques­tion the fu­ture of FDA's reg­u­la­tion of AI in man­u­fac­tur­ing

3 years ago
AI
Manufacturing

FDA hands down par­tial hold for Sun Phar­ma's alope­cia JAK can­di­date

3 years ago
FDA+

With Covid sales de­clin­ing, Pfiz­er ze­roes in on M&A and on­col­o­gy

3 years ago

Sanofi taps pow­er of Paris Olympic spon­sor­ship to en­cour­age em­ploy­ees to find their 'po­ten­tial'

3 years ago
Marketing

Mar­ket­ingRx roundup: No­vo col­lab­o­rates with ath­lete liv­ing with di­a­betes; J&J, GSK and more de­but aware­ness ef­forts

3 years ago
Marketing

Sum­it­o­mo to make 200+ staff cuts in Mass­a­chu­setts amid con­sol­i­da­tion

3 years ago
People

Pfiz­er culls some Are­na-ac­quired pro­grams as it looks to­ward new launch­es

3 years ago
R&D

More than two dozen at­tor­neys gen­er­al push Medicare to cov­er new Alzheimer's treat­ments

3 years ago

Prometheus re­port­ed­ly drew a com­pet­ing Ab­b­Vie bid, ini­tial part­ner in­ter­est from 16 phar­mas be­fore ink­ing $10.8B Mer­ck buy­out

3 years ago
Deals

Bris­tol My­er­s' CAR-T Breyanzi hits end­points in two lym­phoma stud­ies

3 years ago
R&D
Cell/Gene Tx

Bio­gen prices new ALS drug at more than $14K per dose

3 years ago

Vi­iV and Gilead hit im­passe in HIV ad­ver­tis­ing dis­pute, me­di­a­tor sends case to feds for re­view

3 years ago
Marketing

Phar­ma TV drug ads surge among more than half of lead­ing health con­di­tion cat­e­gories in Q1

3 years ago
Marketing

Mile­stone Mon­day for Im­mat­ics’ Bris­tol My­ers-al­lied cell ther­a­py and 2sev­en­ty bio’s No­vo-part­nered he­mo­phil­ia A work

3 years ago
Financing
Cell/Gene Tx

Sanofi's next chap­ter in Pompe: $150M for Maze pact as the biotech gears up in CKD

3 years ago
Startups
Deals

Astel­las to buy Iver­ic Bio for $5.9B in cash as biotech awaits Au­gust FDA nod in reti­nal dis­ease

3 years ago
Deals

FDA ad­vi­so­ry com­mit­tee votes against plan for broad use of prostate can­cer drug

3 years ago
FDA+

Fed­er­al judge rules against Mod­er­na in vac­cine IP suit

3 years ago
Law

Ot­su­ka and Lund­beck get FDA nod for schiz­o­phre­nia, bipo­lar dis­or­der in­jec­tion

3 years ago
First page Previous page 125126127128129130131 Next page Last page
A service from the Financial Times